» Articles » PMID: 29795015

Multidisciplinary Approach for Bone Metastasis: A Review

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2018 May 26
PMID 29795015
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Progress in cancer treatment has improved the survival of patients with advanced-stage cancers. Consequently, the clinical courses of patients are prolonged and often accompanied by morbidity due to bone metastases. Skeletal-related events (SREs), such as pathological fractures and spinal paralysis, cause impairment in activities of daily life and quality of life (QOL). To avoid serious SREs causing impairment in QOL and survival, early diagnosis and a prophylactic approach are required. It is necessary to initiate a bone management program concurrently with the initiation of cancer treatment to prevent complications of bone metastasis. In addition, the requirement of a multidisciplinary approach through a cancer board focusing on the management of bone metastases and involving a team of specialists in oncology, palliative care, radiotherapy, orthopedics, nuclear medicine, radiology, and physiatrists has been emphasized. In the cancer board, a strong focus is placed on the prevention of complications due to bone metastases and on reductions in the high morbidity, hospitalization rate, and overall costs associated with advanced-stage cancers. Recent reports suggest the usefulness of such approaches. The multidisciplinary approach through a cancer board would improve QOL and prognosis of patients, leading to new or continued systemic therapy for primary cancers.

Citing Articles

Standardization of a Model of Vertebral Metastasis of Breast Cancer in CD1/Nu/Nu Mice.

Reyes Soto G, Miranda-Galvan V, Uribe-Uribe N, Escobar-Valderrama J, Alanis-Mendizabal J, Medina-Velazquez L Cureus. 2025; 17(1):e77291.

PMID: 39931605 PMC: 11809943. DOI: 10.7759/cureus.77291.


Lung cancer exosomal Gal3BP promotes osteoclastogenesis with potential connotation in osteolytic metastasis.

Ghanta P, Hessel E, Arias-Alvarado A, Aghayev M, Ilchenko S, Kasumov T Sci Rep. 2024; 14(1):27201.

PMID: 39516568 PMC: 11549321. DOI: 10.1038/s41598-024-79006-w.


Effects of Palliative Surgical Treatment for Spinal Metastases on the Patient's Quality of Life With a Focus on the Segment of the Metastasis: A Prospective Multicenter Study.

Segi N, Nakashima H, Ito S, Ouchida J, Shiratani Y, Shimizu T Global Spine J. 2024; :21925682241297948.

PMID: 39484810 PMC: 11559722. DOI: 10.1177/21925682241297948.


Physical therapist management and coordination of care to prevent pathological hip fracture from metastatic disease: a case report.

Manzino A, Wilson C Front Rehabil Sci. 2024; 5:1384782.

PMID: 39363992 PMC: 11446967. DOI: 10.3389/fresc.2024.1384782.


Multidisciplinary Treatment for Breast Cancer-related Multiple Bone Metastases during Pregnancy Using Bone Metastasis Cancer Boards: A Case Report.

Kashima R, Yoshikawa R, Saho W, Nakamura K, Tsuda Y, Harada R Prog Rehabil Med. 2024; 9:20240032.

PMID: 39359879 PMC: 11443026. DOI: 10.2490/prm.20240032.


References
1.
McKay R, Haider B, Duh M, Valderrama A, Nakabayashi M, Fiorillo M . Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases. Prostate Cancer Prostatic Dis. 2017; 20(3):276-282. DOI: 10.1038/pcan.2017.4. View

2.
Pezaro C, Omlin A, Lorente D, Nava Rodrigues D, Ferraldeschi R, Bianchini D . Visceral disease in castration-resistant prostate cancer. Eur Urol. 2013; 65(2):270-273. PMC: 4881819. DOI: 10.1016/j.eururo.2013.10.055. View

3.
van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9):1437-49. DOI: 10.1093/annonc/mdm056. View

4.
Howard L, De Hoedt A, Aronson W, Kane C, Amling C, Cooperberg M . Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?. Prostate Cancer Prostatic Dis. 2016; 19(4):380-384. PMC: 5542570. DOI: 10.1038/pcan.2016.26. View

5.
Coleman R . Skeletal complications of malignancy. Cancer. 1997; 80(8 Suppl):1588-94. DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z. View